Clinical Trial Update: Genomics of Primary Sclerosing Cholangitis (PSC)

View source ↗

Summary

A Mayo Clinic-sponsored genomics study on Primary Sclerosing Cholangitis has completed, according to the clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Snippet

Sponsor: Mayo Clinic | Conditions: Primary Sclerosing Cholangitis (PSC) | Status: COMPLETED